The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hima Bindu Potluri
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter Hima Bindu Potluri released a pledge on 1,06,20,000 equity shares (11.34% of total share capital) of SMS Pharmaceuticals on 3rd November 2025. Her pledged holdings dropped from 1,36,20,000 shares (14.54%) to 30,00,000 shares (3.20%) after this release. Her total promoter holding in the company remains unchanged at 1,50,08,840 shares (16.03%). The released shares were earlier pledged as security for debentures issued by VKT Pharma Private Limited (an associate company) and Potluri Laboratories Private Limited, with Vistra ITCL as debenture trustee and Avendus Finance and Avendus PE Investment Advisors as debenture holders.
This is a positive development for shareholders. The promoter's pledged shares have reduced sharply from 14.54% to 3.20%, significantly lowering the risk of forced selling or margin calls and improving confidence in the promoter's financial position.